The Board of Jeil Pharmaceutical Co., Ltd. has authorized a buyback plan on November 7, 2013.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10,550 KRW | +2.03% | -0.85% | -10.37% |
2023 | Jeil Pharma Holdings Inc Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2022 | Jeil Pharma Holdings Inc's Equity Buyback Plan Extended till October 2, 2042. | CI |
1st Jan change | Capi. | |
---|---|---|
-10.37% | 117M | |
+16.46% | 42.32B | |
+15.64% | 21.29B | |
+19.33% | 15.29B | |
+18.80% | 14.36B | |
+51.25% | 12.81B | |
-0.05% | 6.79B | |
-12.02% | 6.58B | |
-8.87% | 5.73B | |
+14.28% | 5.51B |
- Stock Market
- Equities
- A002620 Stock
- News Jeil Pharma Holdings Inc
- Jeil Pharmaceutical Co., Ltd. authorizes a Buyback Plan.